Conformis Announces First Procedure Performed Using New Actera™ Hip System
BILLERICA, Mass., Nov. 29, 2022 (GLOBE NEWSWIRE) — Conformis, Inc. (NASDAQ:CFMS), a leading medical device company that features personalized knee and hip replacement products, today announced that the first procedure with the company’s new Actera™ Hip System has been performed.
Related news for (CFMS)
- CONFORMIS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Conformis, Inc. – CFMS
- Conformis, Inc. to Participate in Upcoming Investor Conferences
- Conformis Provides Business Update and Reports Preliminary Results for Fourth Quarter and Full-Year 2022